---
schema_version: "secwatch.filing_event.v1"
accession: "0000883984-22-000044"
form_type: "8-K"
ticker: "ICUI"
cik: "0000883984"
company_name: "ICU MEDICAL INC/DE"
filed_at: "2022-11-07T23:59:59+00:00"
generated_at: "2026-06-22T06:16:14.227658+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# ICU Medical Q3 2022 revenue $597.9M; GAAP loss $(0.55)/share; adj EPS $1.75

## Summary
- Revenue $597.9M vs $336.1M YoY (+78%); GAAP net loss $(13.2)M ($(0.55)/diluted share).
- Adjusted diluted EPS $1.75 vs $2.07 YoY; adjusted EBITDA $92.6M vs $71.9M.
- GAAP gross margin 31% vs 38% YoY; gross profit $186.4M vs $127.8M.
- Reaffirmed fiscal year 2022 guidance; no specific guidance numbers provided.

## SEC filing metadata
- accession: 0000883984-22-000044
- form_type: 8-K
- ticker: ICUI
- cik: 0000883984
- company_name: ICU MEDICAL INC/DE
- filed_at: 2022-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883984/000088398422000044/0000883984-22-000044-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883984/000088398422000044/icui-20221107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000883984-22-000044
- JSON: https://secwatch.observer/filing/0000883984-22-000044.json
- Plain text: https://secwatch.observer/filing/0000883984-22-000044.txt

## Key facts
- Earnings Releases
  ICU MEDICAL INC/DE reported For the quarter ended September 30, 2022 results: revenue Third quarter 2022 revenue was $597.9 million, net income GAAP net loss for the third quarter of 2022 was $(13.2) million, EPS Adjusted diluted earnings per share for the third quarter of 2022 was $1.75. Guidance reaffirmed.
  - Period: For the quarter ended September 30, 2022
  - Revenue: Third quarter 2022 revenue was $597.9 million
  - Net income: GAAP net loss for the third quarter of 2022 was $(13.2) million
  - EPS: Adjusted diluted earnings per share for the third quarter of 2022 was $1.75
  - Guidance: reaffirmed
  - Result: reported results
  source text: ICU Medical Announces Third Quarter 2022 Results The Company Reaffirms 2022 Fiscal Year Guidance
  evidence_url: https://www.sec.gov/Archives/edgar/data/883984/000088398422000044/0000883984-22-000044-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.